SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Mangalam Drugs and Organics reports consolidated net loss of Rs 7.35 crore in the September 2025 quarter

Nov 21,2025

Net loss of Mangalam Drugs and Organics reported to Rs 7.35 crore in the quarter ended September 2025 as against net profit of Rs 2.69 crore during the previous quarter ended September 2024. Sales declined 38.23% to Rs 49.26 crore in the quarter ended September 2025 as against Rs 79.75 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	49.26	79.75	-38
OPM %	-5.77	10.91	-
PBDT	-7.84	5.17	PL
PBT	-12.47	1.20	PL
NP	-7.35	2.69	PL

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,596.41 247.62 (2.39%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)